<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2176</journal-id>
<journal-title><![CDATA[Revista Cubana de Oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Oftalmol]]></abbrev-journal-title>
<issn>0864-2176</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21762015000100013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevención de ceguera por retinopatía diabética: ¿dónde estamos?]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevention of blindness caused by diabetic retinopathy in Cuba, how far have we gone?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Rodríguez]]></surname>
<given-names><![CDATA[Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Cubano de Oftalmología Ramón Pando Ferrer  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2015</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>0</fpage>
<lpage>0</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21762015000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21762015000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21762015000100013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[La diabetes es una de las cuatro enfermedades no transmisibles prioritarias identificadas por la Organización Mundial de la Salud, junto con la enfermedad cardiovascular, el cáncer y la enfermedad respiratoria crónica. En este siglo XXI se habla de una "epidemia global de diabetes", fenómeno relacionado particularmente con la diabetes mellitus tipo II y que está teniendo lugar tanto en países desarrollados como en aquellos en vías de desarrollo. Cuba se une desde 1999 a la iniciativa Visión 2020 y desarrolla desde la propia fecha un plan de prevención de ceguera y baja visión. Hoy, donde la prevalencia de diabetes aumenta, asociada al aumento de la esperanza de vida y a los cambios en el estilo de vida, los oftalmólogos cubanos trabajamos en la prevención de la ceguera por retinopatía diabética. En esta revisión nos proponemos analizar dónde estamos en relación con la Guía práctica clínica de retinopatía diabética para Latinoamérica, publicada en el 2011.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Diabetes is one of the four prioritized non-communicable illnesses identified by the World Health Organization, along with the cardiovascular illnesses, cancer and chronic respiratory diseases. The 21st century witnesses a "global diabetes epidemics" a phenomenon closely related to type II diabetes mellitus and taking place in both developed and developing countries. Since 1999, Cuba joined the Vision 2020 initiative and has developed a preventive program to prevent blindness and low vision. As prevalence of diabetes increases today, associated to higher life expectancy and changes in lifestyles, the Cuban ophthalmologists are working in the prevention of blindness from diabetic retinopathy. In this review we set out to analyze how far we have advanced regarding the implementation of the practical clinical guideline for diabetic retinopathy for Latin America, published in 2011.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diabetes]]></kwd>
<kwd lng="es"><![CDATA[retinopatía]]></kwd>
<kwd lng="es"><![CDATA[Cuba]]></kwd>
<kwd lng="es"><![CDATA[Latinoamérica]]></kwd>
<kwd lng="en"><![CDATA[diabetes]]></kwd>
<kwd lng="en"><![CDATA[retinopathy]]></kwd>
<kwd lng="en"><![CDATA[Cuba]]></kwd>
<kwd lng="en"><![CDATA[Latin America]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <DIV class="Part"   >        <p   align="right" ><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif"><B>OFTALMOLOG&Iacute;A      Y SOCIEDAD </b></font></p >       <p>&nbsp;</p>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Prevenci&oacute;n      de ceguera por retinopat&iacute;a diab&eacute;tica: &iquest;d&oacute;nde estamos?      </b></font></p>   <FONT size="+1" color="#000000"><B>     <p   align="justify" >&nbsp;</p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="3">Prevention of blindness      caused by diabetic retinopathy in Cuba, how far have we gone?</font></p >       <p   align="justify" >&nbsp;</p >       <p   align="justify" >&nbsp;</p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Dra. Beatriz Rodr&iacute;guez      Rodr&iacute;guez </font></p >   </B>        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Instituto Cubano      de Oftalmolog&iacute;a &quot;Ram&oacute;n Pando Ferrer&quot;. La Habana, Cuba.      </font></p >       ]]></body>
<body><![CDATA[<p   align="justify" >&nbsp;</p >       <p   align="justify" >&nbsp;</p >   </font>    <hr>   <FONT size="+1" color="#000000"> </font></DIV > <FONT size="+1" color="#000000">     <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>RESUMEN </b></font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La diabetes es una      de las cuatro enfermedades no transmisibles prioritarias identificadas por      la Organizaci&oacute;n Mundial de la Salud, junto con la enfermedad cardiovascular,      el c&aacute;ncer y la enfermedad respiratoria cr&oacute;nica. En este siglo      XXI se habla de una &quot;epidemia global de diabetes&quot;, fen&oacute;meno      relacionado particularmente con la diabetes mellitus tipo II y que est&aacute;      teniendo lugar tanto en pa&iacute;ses desarrollados como en aquellos en v&iacute;as      de desarrollo. Cuba se une desde 1999 a la iniciativa Visi&oacute;n 2020 y      desarrolla desde la propia fecha un plan de prevenci&oacute;n de ceguera y      baja visi&oacute;n. Hoy, donde la prevalencia de diabetes aumenta, asociada      al aumento de la esperanza de vida y a los cambios en el estilo de vida, los      oftalm&oacute;logos cubanos trabajamos en la prevenci&oacute;n de la ceguera      por retinopat&iacute;a diab&eacute;tica. En esta revisi&oacute;n nos proponemos      analizar d&oacute;nde estamos en relaci&oacute;n con la Gu&iacute;a pr&aacute;ctica      cl&iacute;nica de retinopat&iacute;a diab&eacute;tica para Latinoam&eacute;rica,      publicada en el 2011. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Palabras clave:</B>      diabetes, retinopat&iacute;a, Cuba, Latinoam&eacute;rica.</font></p >   <hr> </DIV >     <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>ABSTRACT </b></font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Diabetes is one of      the four prioritized non-communicable illnesses identified by the World Health      Organization, along with the cardiovascular illnesses, cancer and chronic      respiratory diseases. The 21st century witnesses a &quot;global diabetes epidemics&quot;      a phenomenon closely related to type II diabetes mellitus and taking place      in both developed and developing countries. Since 1999, Cuba joined the Vision      2020 initiative and has developed a preventive program to prevent blindness      and low vision. As prevalence of diabetes increases today, associated to higher      life expectancy and changes in lifestyles, the Cuban ophthalmologists are      working in the prevention of blindness from diabetic retinopathy. In this      review we set out to analyze how far we have advanced regarding the implementation      of the practical clinical guideline for diabetic retinopathy for Latin America,      published in 2011.</font></p >       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Key words:</b>      diabetes, retinopathy, Cuba, Latin America.</font></p>   <hr> </DIV >     ]]></body>
<body><![CDATA[<DIV class="Part"   >        <p>&nbsp;</p>       <p>&nbsp;</p>       <p>&nbsp;</p>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">INTRODUCCI&Oacute;N      </font> </b></font></p>       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La diabetes es una      de las cuatro enfermedades no transmisibles prioritarias identificadas por      la Organizaci&oacute;n Mundial de la Salud, junto con la enfermedad cardiovascular,      el c&aacute;ncer y la enfermedad respiratoria cr&oacute;nica. En este siglo      XXI se habla de una &quot;Epidemia Global de diabetes&quot;, fen&oacute;meno      relacionado particularmente con la diabetes mellitus tipo II y que est&aacute;      teniendo lugar tanto en pa&iacute;ses desarrollados como en aquellos en v&iacute;as      de desarrollo.<Sup>1-2 </Sup>Existen intervenciones probadas y factibles que      pueden prevenir en gran medida la diabetes y sus complicaciones y, sin embargo,      la diabetes sigue matando y discapacitando a millones de personas en el mundo      cada a&ntilde;o. </font></p >       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Un enfoque preventivo      tiene como base la conservaci&oacute;n, el cuidado y la restauraci&oacute;n      de la salud para no perderla o para mejorarla al m&aacute;ximo, lo que representa,      a la par, una incuestionable reducci&oacute;n en cuanto a costos para la salud,      ya que resulta m&aacute;s caro el tratamiento, el control y la rehabilitaci&oacute;n      que su prevenci&oacute;n.<Sup>3 </Sup></font></p>       <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En el diab&eacute;tico      de larga data de evoluci&oacute;n, y por efecto del mal control metab&oacute;lico,      se presenta da&ntilde;o en los peque&ntilde;os vasos (microangiopat&iacute;as)      y en los grandes vasos (macroangiopat&iacute;a). El avance de las ciencias      m&eacute;dicas encamina todo su esfuerzo hacia la prevenci&oacute;n de estas      complicaciones.<Sup>4 </Sup> En el a&ntilde;o 2002, el promedio global de      riesgo de ceguera causado por la retinopat&iacute;a diab&eacute;tica se calcul&oacute;      en un 0,75 %. Esto significa que de cada 133 personas con diabetes, una se      quedar&aacute; ciega.<Sup>5 </Sup>Si aplicamos esta estad&iacute;stica al      n&uacute;mero de personas a quienes se les espera haber pronosticado diabetes      en el a&ntilde;o 2035, la cifra de personas que probablemente queden ciegas      por causa de la retinopat&iacute;a diab&eacute;tica ser&iacute;a de 4,4 millones.      </font></p>   <FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La retinopat&iacute;a      diab&eacute;tica (RD) por lo general se desarrolla entre los 10 y los 20 a&ntilde;os,      luego del inicio de la diabetes, y progresa m&aacute;s r&aacute;pido cuando      dicha enfermedad no se diagnostica o no se trata a tiempo. Teniendo en cuenta      esta demora, a pesar del incremento de pacientes con diabetes para el 2035,      a&uacute;n contamos con tiempo para actuar en el diagn&oacute;stico precoz      y el tratamiento oportuno de la retinopat&iacute;a diab&eacute;tica para prevenir      la p&eacute;rdida visual, mejorando la calidad de vida de los pacientes. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La Federaci&oacute;n      Internacional de Diabetes, en el documento que plantea el plan mundial contra      la diabetes 2011-2021, reconoce: la diabetes se encuentra a niveles de crisis.      No podemos permitirnos retrasar la acci&oacute;n a&uacute;n m&aacute;s; la      miseria y el sufrimiento humano que causa la diabetes son inaceptables e insostenibles.<Sup>6      </Sup></font></p >   <FONT size="+1">        ]]></body>
<body><![CDATA[<p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En Oftalmolog&iacute;a,      en los a&ntilde;os 90, se dan voces de alarma con el documento hist&oacute;rico      &quot;Visi&oacute;n al Futuro&quot;, a iniciativa del Concilio y la Academia      Oftalmol&oacute;gica Internacional, el cual sugiere un plan estrat&eacute;gico      para preservar y restaurar la visi&oacute;n, lo que se suma al esfuerzo mundial      del Programa VISION 2020, bajo el liderazgo de la Organizaci&oacute;n Mundial      de la Salud y de la Agencia Internacional para la Prevenci&oacute;n de Ceguera.      En este escenario, VISION 2020 en Am&eacute;rica Latina decidi&oacute; crear      el subcomit&eacute; para el an&aacute;lisis continental de la retinopat&iacute;a      diab&eacute;tica.<Sup>7 </Sup></font></p >   <FONT size="+1"><FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Cuba se une desde      1999 a la iniciativa Visi&oacute;n 2020 y desarrolla desde la propia fecha      un plan de prevenci&oacute;n de ceguera y baja visi&oacute;n. Hoy, donde la      prevalencia de diabetes aumenta, asociada al aumento de la esperanza de vida      y a los cambios en el estilo de vida, los oftalm&oacute;logos cubanos trabajamos      en la prevenci&oacute;n de ceguera por retinopat&iacute;a diab&eacute;tica.      En esta revisi&oacute;n nos proponemos analizar d&oacute;nde estamos en relaci&oacute;n      con la gu&iacute;a pr&aacute;ctica cl&iacute;nica de retinopat&iacute;a diab&eacute;tica      para Latinoam&eacute;rica, publicada en el 2011.<Sup>7 </Sup></font></p >   <FONT size="+1"><FONT size="+1">        <p   align="justify" >&nbsp;</p >   </font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > <FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>GU&Iacute;A      PR&Aacute;CTICA &quot;CL&Iacute;NICA DE RETINOPAT&Iacute;A DIAB&Eacute;TICA      PARA LATINOAM&Eacute;RICA&quot;</b></font></p>       <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Por iniciativa del      Subcomit&eacute; de Retinopat&iacute;a Diab&eacute;tica del programa Visi&oacute;n      2020, de la Agencia Internacional para la Prevenci&oacute;n de Ceguera, se      realizaron dos talleres en Latinoam&eacute;rica que permiti&oacute; desarrollar      una gu&iacute;a de orientaci&oacute;n, aunando el esfuerzo de un grupo de      expertos de varios pa&iacute;ses y organizaciones que realizaron una revisi&oacute;n      de la literatura y de la evidencia existente. Discutieron estrategias y planes      de acci&oacute;n que permitieron desarrollar un protocolo de orientaci&oacute;n      para programas de prevenci&oacute;n de ceguera en retinopat&iacute;a diab&eacute;tica      en Latinoam&eacute;rica y el Caribe. El primer taller tuvo lugar en Quito,      Ecuador (15 y 16 de abril de 2009) y el segundo se efectu&oacute; en Quer&eacute;taro,      M&eacute;xico (11 y 12 de octubre de 2010). Ambos foros arribaron a las siguientes</font><font face="Verdana, Arial, Helvetica, sans-serif">      </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">consideraciones      generales: </font></p >   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-        La retinopat&iacute;a diab&eacute;tica es la tercera causa de ceguera a        nivel mundial pero la primera en personas de edad productiva en pa&iacute;ses        en v&iacute;as de desarrollo. La Organizaci&oacute;n Mundial de la Salud        estima que la retinopat&iacute;a diab&eacute;tica produce casi 5 % de los        37 millones de ciegos del mundo.</font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          ]]></body>
<body><![CDATA[<p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-No        mata, no duele y, por mala informaci&oacute;n, muchos pacientes consultan        tard&iacute;amente al oftalm&oacute;logo, al perder visi&oacute;n, y pueden        quedar ciegos en forma irreversible. </font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-Es        fundamental la educaci&oacute;n para promover en el paciente y en sus familiares        el autocuidado. Un buen control metab&oacute;lico retarda la aparici&oacute;n        y la progresi&oacute;n de las lesiones existentes. </font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-La        ceguera por retinopat&iacute;a diab&eacute;tica es prevenible en el 80 %        de los casos con una detecci&oacute;n y un tratamiento temprano asociado        a un manejo general. El 10 % de los pacientes con diabetes tienen una limitaci&oacute;n        visual severa y el 2 % de ellos llega a la ceguera. </font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-El        edema macular se puede presentar en cualquier etapa de una retinopat&iacute;a        diab&eacute;tica y es la causa m&aacute;s importante de limitaci&oacute;n        visual, lo que se relaciona con un mayor tiempo de evoluci&oacute;n. La        hemorragia v&iacute;trea es la causa m&aacute;s frecuente de ceguera, asociada        a etapas de retinopat&iacute;a proliferativa. </font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">-La        prevalencia y la incidencia de la retinopat&iacute;a diab&eacute;tica est&aacute;        aumentando y se duplicar&aacute;n los casos hacia el a&ntilde;o 2030. </font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Ellos proponen    que esto debe traducirse en la creaci&oacute;n de programas nacionales para    la atenci&oacute;n temprana de la retinopat&iacute;a diab&eacute;tica, mediante    la capacitaci&oacute;n al oftalm&oacute;logo de pr&aacute;ctica general y al    residente en el manejo de esta enfermedad, con el uso de una clasificaci&oacute;n    simplificada y un manejo adecuado de las etapas de la RD. Plantean que al iniciar    un programa de prevenci&oacute;n de ceguera por retinopat&iacute;a diab&eacute;tica,    se debe considerar lo siguiente: </font></p>     ]]></body>
<body><![CDATA[<blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font size="2">a)<FONT color="#000000">        Contar con una gu&iacute;a cl&iacute;nica de retinopat&iacute;a diab&eacute;tica        con una clasificaci&oacute;n simplificada, el intervalo de control y la        sugerencia de tratamiento. <font color="#000000"><font size="2">La agudeza        visual no se considera en ninguna etapa, ya que se afecta en etapas tard&iacute;as.        </font></font></font></font><FONT color="#000000"><font size="2">La retinopat&iacute;a        ha sido clasificada de diferentes formas; algunos de esos sistemas son demasiado        complejos y sirven solamente como herramientas de investigaci&oacute;n.        Se sugiri&oacute; una clasificaci&oacute;n simplificada como una forma simple        de evaluar el estado del fondo de ojo y con esto definir el manejo, el tratamiento        y el control de un paciente afectado (<a src="/img/revistas/oft/v28n1/c0113115.gif">cuadro 1</a>).<Sup>8        </Sup></font></font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">b.        Elegir un m&eacute;todo de tamizaje, considerando equipamiento y recurso        humano. </font><font color="#000000"><font color="#000000"><font size="2">La        poblaci&oacute;n a tamizar es todo paciente diab&eacute;tico registrado        y se realizar&aacute; en dependencia de las posibilidades en cada regi&oacute;n.        </font><font color="#000000"><font color="#000000"><font size="2">Los m&eacute;todos        de detecci&oacute;n que se propusieron fueron:</font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>        <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-<i>          Fondo de ojo realizado por el oftalm&oacute;logo:</i> el examen debe ser          realizado con una l&aacute;mpara de hendidura, con lupa y con la pupila          dilatada. Es un sistema &quot;gold est&aacute;ndar&quot;, con mayor especificidad          y sensibilidad, contra el cual se comparan los otros sistemas de tamizaje.</font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000">-          <font color="#000000"><font color="#000000"><font size="2"><i>Fondo de          ojo realizado por un m&eacute;dico no oftalm&oacute;logo:</i> con oftalmoscopio          directo sin dilatar la pupila; es muy poco sensible y espec&iacute;fico.          No se recomienda. </font></font></font> </font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          ]]></body>
<body><![CDATA[<DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2"><i>-          Fondo de ojo con c&aacute;maras fotogr&aacute;ficas:</i> los sistemas          fotogr&aacute;ficos digitales se han evaluado y logran una sensibilidad          y especificidad comparable a la forma tradicional delfondo de ojo. Este          es un procedimiento r&aacute;pido, f&aacute;cil de realizar, conveniente          para el paciente y, principalmente, es costo-efectivo, ya que solamente          los pacientes con retinopat&iacute;a diab&eacute;tica son referidos al          oftalm&oacute;logo, y se emplea personal menos calificado en la etapa          inicial del proceso. </font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">c.        Generar centros de tratamiento de l&aacute;ser temprano y oportuno. </font></font></font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font color="#000000"><font size="2">Se        plante&oacute; contar con un Centro de fotocoagulaci&oacute;n por cada 250        000 a 500 000 habitantes. Se requiere contar con un Centro de Cirug&iacute;a        para vitrectom&iacute;a en una poblaci&oacute;n de un mill&oacute;n de habitantes        y realizar un m&iacute;nimo de 500 cirug&iacute;as al a&ntilde;o. Asimismo,        se orient&oacute; el manejo de la retinopat&iacute;a que se muestra en el        <a src="/img/revistas/oft/v28n1/c0213115.gif">cuadro 2</a> como una gu&iacute;a r&aacute;pida.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >     <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">d.        Educaci&oacute;n al paciente con diabetes sobre el riesgo de la p&eacute;rdida        visual y la ceguera. Qued&oacute; claro que la educaci&oacute;n es prioritaria        en la prevenci&oacute;n y debe contener mensajes claros para el paciente        y su familia, mediante la promoci&oacute;n del autocuidado del paciente        y de la poblaci&oacute;n en riesgo. Por cualquier medio que se use se debe        difundir a la poblaci&oacute;n en general que:</font></font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>        <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          la diabetes conlleva un riesgo real de ceguera.    <br>         </font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          ]]></body>
<body><![CDATA[<DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          El control metab&oacute;lico estricto es esencial para evitar la p&eacute;rdida          visual.    <br>         </font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          La retinopat&iacute;a diab&eacute;tica es asintom&aacute;tica y se detecta          por un fondo de ojo, y es esencial un examen anual de la retina.    <br>         </font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          El tratamiento ayuda a preservar la visi&oacute;n &uacute;til.     <br>         </font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            ]]></body>
<body><![CDATA[<p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          El oftalm&oacute;logo debe evaluar, clasificar y tratar una retinopat&iacute;a          diab&eacute;tica.</font></font></font></p>       <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">-          La educaci&oacute;n del paciente diab&eacute;tico es una funci&oacute;n          de todos. Los tres niveles de atenci&oacute;n est&aacute;n inmersos en          esto.</font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">e.        Considerar sustentabilidad a largo plazo, mediante copago o subsidios. </font></font></font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>  </blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >       <p><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><FONT color="#000000"><font size="2">Se      hace necesario realizar abogac&iacute;a para iniciar un programa de manejo      de la retinopat&iacute;a diab&eacute;tica. La abogac&iacute;a es la capacidad      de influir en actores con poder de decisi&oacute;n, para desarrollar procesos      que permitan mejorar los problemas de salud visual de los grupos m&aacute;s      vulnerables. </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font color="#000000"><font size="2">El      plan de acci&oacute;n empieza con una estrategia de soluci&oacute;n coherente      con la realidad local, dirigido a la poblaci&oacute;n m&aacute;s vulnerable,      asegurando mayor cobertura, calidad de la atenci&oacute;n y ser autosustentable.      </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" face="Verdana, Arial, Helvetica, sans-serif"><font color="#000000"><font size="2">Para      que el plan a largo plazo genere un impacto social se necesita de recursos      y de voluntad pol&iacute;tica. </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>       <p>&nbsp;</p>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><font size="3">PROGRAMA      DE PREVENCI&Oacute;N DE CEGUERA POR RETINOPAT&Iacute;A DIAB&Eacute;TICA EN      CUBA</font></b></font></p>    </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        ]]></body>
<body><![CDATA[<p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Los profesores Dr.      <i>Sergio Vidal Casali</i> y DCs. <i>Rolando L&oacute;pez Cardet</i>, pioneros      de la subespecialidad de la retina en Cuba, aunaron sus esfuerzos para desarrollar      el programa de prevenci&oacute;n por ceguera por retinopat&iacute;a diab&eacute;tica,      y en el a&ntilde;o 2004, con la Misi&oacute;n Milagro, logramos la formaci&oacute;n      de un n&uacute;mero considerable de retin&oacute;logos, ademas de la adquisici&oacute;n      de equipamiento necesario para desarrollar el programa. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Por iniciativa del      Servicio de V&iacute;treorretina del Instituto Cubano de Oftalmolog&iacute;a      &quot;Ram&oacute;n Pando Ferrer&quot;, en el a&ntilde;o 2008 se comenz&oacute;      a realizar talleres nacionales de la subespecialidad, y en el 2009 fue dedicado      al Programa nacional de prevenci&oacute;n de ceguera por retinopat&iacute;a      diab&eacute;tica, al igual que en el 2014, donde &#151;teniendo en cuenta      la Gu&iacute;a de pr&aacute;ctica cl&iacute;nica de retinopat&iacute;a diab&eacute;tica      para Latinoam&eacute;rica</font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#151;</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">      </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> realizamos      un an&aacute;lisis comparativo con el programa cubano, utilizando las mismas      consideraciones:</font></p > </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">a) Contar con una      gu&iacute;a cl&iacute;nica de retinopat&iacute;a diab&eacute;tica con una      clasificaci&oacute;n simplificada, el intervalo de control y la sugerencia      de tratamiento. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">Tenemos      un protocolo de actuaci&oacute;n asistencial para la retinopat&iacute;a diab&eacute;tica,      publicada dentro del Manual de diagnostico y tratamiento en Oftalmolog&iacute;a,      del Instituto cubano de oftalmolog&iacute;a &quot;Ram&oacute;n Pando Ferrer&quot;.      Adem&aacute;s, poseemos un programa nacional para la prevenci&oacute;n de      la ceguera por retinopat&iacute;a diab&eacute;tica, publicado en la p&aacute;gina      web del Instituto, lo que facilita los conocimientos necesarios tanto para      la prevenci&oacute;n como para el diagn&oacute;stico precoz y el tratamiento      oportuno de la retinopat&iacute;a diab&eacute;tica cuando esta se haga presente.<sup>9,10          <br>         <br>     </sup></font> </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">b) Elegir un        m&eacute;todo de tamizaje, considerando equipamiento y recurso humano. </font><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En        Cuba se utiliza el m&eacute;todo de tamizaje a trav&eacute;s del fondo de        ojo por el oftalm&oacute;logo general de la atenci&oacute;n primaria de        salud, ya que contamos en este nivel de atenci&oacute;n con todos los paciente        diab&eacute;ticos dispensarizados, ademas de personal m&eacute;dico especializado        en Oftalmolog&iacute;a general, con equipamiento necesario para realizar        el fondo de ojo con pupila dilatada, para detectar personas con alg&uacute;n        signo de retinopat&iacute;a (<a src="/img/revistas/oft/v28n1/f0113115.jpg">Fig. 1</a>).</font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">        A&uacute;n tenemos dificultades con lograr el control oftalmol&oacute;gico        anual en los pacientes diab&eacute;ticos, en lo cual nos mantenemos trabajando        de forma activa.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1"><FONT size="+1">        </font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">c)        Generar centros de tratamiento de l&aacute;ser temprano y oportuno. </font></font></font><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Los        pacientes con alg&uacute;n signo de retinopat&iacute;a son enviados a la        atenci&oacute;n secundaria, donde tenemos retin&oacute;logos u oftalm&oacute;logos        acreditados para la atenci&oacute;n al paciente diab&eacute;tico con retinopat&iacute;a.        En este nivel de atenci&oacute;n son clasificados y tratados y se les da        seguimiento y los casos complicados que requieran cirug&iacute;a o tratamiento        con antiangiog&eacute;nico son enviados a la atenci&oacute;n terciaria al        Servicio de V&iacute;treorretina del Instituto cubano de oftalmolog&iacute;a        &quot;Ram&oacute;n Pando Ferrer&quot; </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">(<a src="/img/revistas/oft/v28n1/f0113115.jpg">F</a></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><a src="/img/revistas/oft/v28n1/f0113115.jpg"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">ig.        1</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="2">).        En el pa&iacute;s contamos con 21 centros de atenci&oacute;n secundaria        para tratamientos de fotocoagulaci&oacute;n en el diab&eacute;tico. Un centro        de atenci&oacute;n por cada 531 616 habitantes. Seg&uacute;n el anuario        estad&iacute;stico de salud, tenemos una prevalencia de 53,7 por 1 000 habitantes.<Sup>11</Sup>        En Cuba el n&uacute;mero total de diab&eacute;ticos es de 599 503 y si se        considera que entre el 5 y el 8 % tendr&aacute; retinopat&iacute;a que requiere        de tratamiento con l&aacute;ser, entonces tendr&iacute;amos entre 29 975        y 47 960 diab&eacute;ticos que requerir&aacute;n de tratamiento de l&aacute;ser,        por lo que un centro de tratamiento tendr&aacute; que tratar entre 1 427        y 3 837 pacientes. El Centro para tratamiento quir&uacute;rgico se encuentra        solamente en la capital del pa&iacute;s, en tres hospitales, con un total        de 6 posiciones quir&uacute;rgicas. </font></font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        ]]></body>
<body><![CDATA[<DIV class="Part"   >          <p><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">d)        Educaci&oacute;n al paciente con diabetes sobre el riesgo de p&eacute;rdida        visual y ceguera.</font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">        La educaci&oacute;n en nuestro programa es tarea de todos, tanto del personal        m&eacute;dico en los tres niveles de atenci&oacute;n, como del personal        para medico, tambi&eacute;n de los medios de difusi&oacute;n masivas. Los        </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">medios        de difusi&oacute;n que usamos son las charlas educativas, la confecci&oacute;n        de plegables o carteles y los medios de difusi&oacute;n masiva escrita,        audio y televisi&oacute;n:</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>        <blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">-        <i>La atenci&oacute;n primaria:</i> donde se realiza la prevenci&oacute;n        y el diagn&oacute;stico precoz de la </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">retinopat&iacute;a.        La educaci&oacute;n va encaminada a</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        : </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <ul>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">            Mantener actualizado el registro de pacientes diab&eacute;ticos dispensarizados.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <br>       </li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">            La correcci&oacute;n precoz de los factores de riesgo modificables.    <br>               ]]></body>
<body><![CDATA[<br>           </font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Lograr            control metab&oacute;lico estricto, esencial para evitar la p&eacute;rdida            visual.    <br>               <br>           </font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Involucrar            a todos los m&eacute;dicos relacion&aacute;ndolos con el tema.    <br>               <br>           </font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              ]]></body>
<body><![CDATA[<DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Educar            al </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">            personal de atenci&oacute;n primaria, la cual debe incluir debe incluir            a </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">enfermeros,            trabajadores sociales y personal param&eacute;dico;</font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">            sensibilizar al personal m&eacute;dico relacionado con la atenci&oacute;n            del diab&eacute;tico para que envi&eacute; al paciente a la consulta            del oftalm&oacute;logo</font></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">            y </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">educar            al paciente y familiares en el cuidado de su enfermedad y en la importancia            del examen oftalmol&oacute;gico. </font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>         </ul>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   ></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">-<i>          La atenci&oacute;n secundaria: </i>donde se realiza la clasificaci&oacute;n          y el tratamiento oportuno de la retinopat&iacute;a:</font></font></font></font></font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <ul>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">            Se realiza la educaci&oacute;n al paciente y a los familiares en la            importancia del tratamiento y el seguimiento de la RD.    <br>               <br>           </font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              ]]></body>
<body><![CDATA[<DIV class="Part"   ><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se            insiste en el control de la diabetes y en la detecci&oacute;n precoz            de otras </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">complicaciones.    <br>               <br>           </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La fotocoagulaci&oacute;n            se completa para lograr su efecto.    <br>               <br>           </font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se sensibiliza al            personal m&eacute;dico relacionado con la atenci&oacute;n al diab&eacute;tico</font><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">            </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">para            que envi&eacute; al paciente a la consulta del oftalm&oacute;logo. </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1">            </font></font></font></font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>         </ul>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">          ]]></body>
<body><![CDATA[<DIV class="Part"   >-<font face="Verdana, Arial, Helvetica, sans-serif" size="2"> </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Atenci&oacute;n        terciaria:</i> donde se intenta restaurar la visi&oacute;n perdida. Tambi&eacute;n        se realizan las siguientes acciones: </font></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <ul>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Educaci&oacute;n            al paciente y a sus familiares en la importancia del tratamiento y del            seguimiento de las formas graves de la retinopat&iacute;a.    <br>               <br>           </font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">C</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">ontrol            de la diabetes y detecci&oacute;n precoz de otras complicaciones no            oculares.     <br>               <br>           </font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>           <li><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">              ]]></body>
<body><![CDATA[<DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Posterior a los tratamientos,            si se presenta visi&oacute;n subnormal, se env&iacute;a al paciente            a las Consultas de Baja visi&oacute;n para la rehabilitaci&oacute;n            visual. </font></DIV >         </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></li>         </ul>   </blockquote>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">e.        Considerar sustentabilidad a largo plazo, mediante copago o subsidios. </font></font></font></font></font></p>         <p>&nbsp;</p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><font size="3">CONCLUSIONES</font></b></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se enumeran algunos    aspectos de la estrategia para lograr el &eacute;xito en la implementaci&oacute;n    del programa de diagn&oacute;stico y tratamiento temprano de la retinopat&iacute;a    diab&eacute;tica en Cuba:</font></p>     <p></p> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   > </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        ]]></body>
<body><![CDATA[<DIV class="Part"   >          <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Realizar        estudios de prevalencia a nivel nacional (</font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">pesquisaje        de retinopat&iacute;a diab&eacute;tica en Cuba</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">).        </font> </p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Datos estad&iacute;sticos        del programa: recogida de los datos que deben enviarse al retin&oacute;logo        responsable del programa en la provincia: </font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>        <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">-Cantidad          de </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">diab&eacute;ticos          vistos por el oftalm&oacute;logo de </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Atenci&oacute;n          Primaria de Salud. </font></p>           <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">-Cantidad          de pacientes diab&eacute;ticos vistos en la consulta de retina, y cu&aacute;ntos          </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">de          ellos</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2">requieren          tratamiento de l&aacute;ser. </font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Lograr        el tamizaje de todos los diab&eacute;ticos: </font></p>     <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>       ]]></body>
<body><![CDATA[<blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">         <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">a) Que los pacientes        diab&eacute;ticos acudan a la consulta del oftalm&oacute;logo de Atenci&oacute;n        Primaria de Salud. </font> </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote> </blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p></p >   <OL   type="1" >         <blockquote>            <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">b) Acercamiento          de los retin&oacute;logos a los m&eacute;dicos de Atenci&oacute;n Primaria;          realizar conferencias, visitas, plegables, entre otros. </font></p>       <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote>   </OL > </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Educaci&oacute;n        del diab&eacute;tico en relaci&oacute;n con los temas de la retinopat&iacute;a        diab&eacute;tica. </font></p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>       <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">         ]]></body>
<body><![CDATA[<DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">a) Divulgaci&oacute;n        por los medios de comunicaci&oacute;n masiva para la educaci&oacute;n de        los pacientes y sus familiares.     <br>           <br>       b) Poster y plegables educativos. </font></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote> </blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   ></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Lograr      sustentabilidad del programa a largo plazo. </font></p> </blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   ></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote>        <blockquote><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">a) Demostrar los        resultados estad&iacute;sticos del programa para darlos a conocer en el        Ministerio de Salud P&uacute;blica, con el fin de que garanticen los medios        necesarios para su desarrollo.    ]]></body>
<body><![CDATA[<br>           <br>       </font></DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">b) Garantizar          la preparaci&oacute;n de tres retin&oacute;logos cl&iacute;nicos como          m&iacute;nimo por centro oftalmol&oacute;gico para la atenci&oacute;n          secundaria.</font></p>           <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> c) Lograr          el mantenimiento de los equipos de l&aacute;ser. </font></p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">          <DIV class="Part"   >            <p>&nbsp;</p>     </DIV >     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote> </blockquote> <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">REFERENCIAS      BIBLIOGR&Aacute;FICAS </font></b></font></p> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        ]]></body>
<body><![CDATA[<!-- ref --><p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1.<b> </b>Zimmet      P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic.      Nature. 2001;414(6865):782-6.     </font></p >       <!-- ref --><p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Barr&iacute;a      F. Diabetes mellitus: una epidemia mundial. Arch Chil Oftalmol. 2008;65(1):63-6.          </font></p >       <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Montano      Luna JA, Prieto D&iacute;az V. Enfoque preventivo y factores de riesgo. En:      Colectivo de autores. Medicina General Integral. Salud y medicina. La Habana:      Editorial Ciencias M&eacute;dicas; 2008. p. 168-70. </font></p > </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <!-- ref --><DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Fowler MJ. Complications    of Diabetes. Clin diab. 2011;29(3)1-10.    <br>       <!-- ref --><br>   </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5.    Winter I, Yoston D. Retinopat&iacute;a diab&eacute;tica: un asunto de todos.    Revista Salud Ocular Comunitaria. 2012 [citado 29 de marzo de 2014];5(10):[aprox    4 p.]. Disponible en: <a href="http://www.baja-vision.org/bnoviembre12/articulo.asp?id=146" target="_blank">http://www.baja-vision.org/bnoviembre12/articulo.asp?id=146</a></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font face="Verdana,     Arial, Helvetica, sans-serif" size="2">    </font>    <br>       ]]></body>
<body><![CDATA[<br> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.</font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">      Federaci&oacute;n Internacional de Diabetes. Plan mundial contra la diabetes      2011-2021 [citado 29 de marzo de 2014]. Disponible en: <a href="http://www.idf.org/sites/default/files/attachments/GDP-Spanish.pdf" target="_blank">http://www.idf.org/sites/default/files/attachments/GDP-Spanish.pdf</a></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Barr&iacute;a      F, Mart&iacute;nez F. Gu&iacute;a pr&aacute;ctica cl&iacute;nica de retinopat&iacute;a      diab&eacute;tica para Latinoam&eacute;rica. Programa Visi&oacute;n 2020/IAPB      Latinoam&eacute;rica, Asociaci&oacute;n Panamericana de Oftalmolog&iacute;a      APAO, Christian Blind Mission. CBM. 2010 [citado 29 de marzo de 2014]. Disponible      en: </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="+1" color="#000000"><a href="https://paao.org/images/Downloads/spanish/pdf/GuiaPracticaRetinopatia2011.pdf" target="_blank"><font size="2">https://paao.org/images/Downloads/spanish/pdf/GuiaPracticaRetinopatia2011.pdf</font></a>      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><div class="Part"   >          <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">Barr&iacute;a        F. Programa de salud ocular en Chile. Soluci&oacute;n integral a la atenci&oacute;n        oftalmol&oacute;gica propuesta por la Sociedad Chilena de Oftalmolog&iacute;a        en el a&ntilde;o 2003. Arch Chil Oftalmol. 2005;62(1-2):15-20.     </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></p>         <div class="Part"   >           <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Eguia          F. Manual de diagn&oacute;stico y tratamiento en Oftalmolog&iacute;a.          La Habana: Editorial Ciencias M&eacute;dicas; 2009.     </font></p>     </div >   </div > </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      ]]></body>
<body><![CDATA[<DIV class="Part"   >        <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Colectivo      de autores. Programa nacional de prevenci&oacute;n de ceguera por retinopat&iacute;a      diab&eacute;tica en Cuba. 2013 </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">[citado      29 de marzo de 2014]. Disponible en: </font><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="+1" color="#000000"><font size="2"><font color="#000033"><a href="http://www.vitreoretina.sld.cu" target="_blank">http:/<font color="#0000FF">/</font></a></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font color="#0000FF"><a href="http://www.vitreoretina.sld.cu" target="_blank"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">www.vitreoretina.sld.cu</font></a><font face="Verdana,     Arial, Helvetica, sans-serif" size="2"><U>      </U></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">    <br>         <!-- ref --><br>     11. MINSAP. Anuario estad&iacute;stico 2013 [citado 12 de noviembre de 2014].      Disponible en: <a href="http://www.sld.cu/servicios/estadisticas" target="_blank">http://www.sld.cu/servicios/estadisticas</a></font><p>&nbsp;</p>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Recibido: 2 de      diciembre de 2014.    <br>     Aprobado: 3 de enero de 2015. </font></p>       <p>&nbsp;</p>       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Dra. <I>Beatriz      Rodr&iacute;guez Rodr&iacute;guez</I>. Instituto Cubano de Oftalmolog&iacute;a      &quot;Ram&oacute;n Pando Ferrer&quot;. Ave. 76 No. 3104 entre 31 y 41 Marianao,      La Habana, Cuba. Correo electr&oacute;nico: <U><FONT color="#0000FF"><a href="mailto:beatrizrr@infomed.sld.cu">beatrizrr@infomed.sld.cu</a>      </font></U></font></p>   </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      ]]></body>
<body><![CDATA[ ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimmet]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Alberti]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Global and societal implications of the diabetes epidemic]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2001</year>
<volume>414</volume>
<numero>6865</numero>
<issue>6865</issue>
<page-range>782-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barría]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus: una epidemia mundial]]></article-title>
<source><![CDATA[Arch Chil Oftalmol]]></source>
<year>2008</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montano Luna]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto Díaz]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Enfoque preventivo y factores de riesgo]]></article-title>
<collab>Colectivo de autores</collab>
<source><![CDATA[Medicina General Integral.Salud y medicina]]></source>
<year>2008</year>
<page-range>168-70</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fowler]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Complications of Diabetes]]></article-title>
<source><![CDATA[Clin diab]]></source>
<year>2011</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winter]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Yoston]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Retinopatía diabética: un asunto de todos]]></article-title>
<source><![CDATA[Revista Salud Ocular Comunitaria]]></source>
<year>2012</year>
<volume>5</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>4</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Federación Internacional de Diabetes</collab>
<source><![CDATA[Plan mundial contra la diabetes 2011-2021]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barría]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Guía práctica clínica de retinopatía diabética para Latinoamérica. Programa Visión 2020/IAPB Latinoamérica, Asociación Panamericana de Oftalmología APAO, Christian Blind Mission]]></article-title>
<source><![CDATA[CBM]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barría]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Programa de salud ocular en ChileSolución integral a la atención oftalmológica propuesta por la Sociedad Chilena de Oftalmología en el año 2003]]></article-title>
<source><![CDATA[Arch Chil Oftalmol]]></source>
<year>2005</year>
<volume>62</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>15-20</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eguia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual de diagnóstico y tratamiento en Oftalmología]]></source>
<year>2009</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Colectivo de autores</collab>
<source><![CDATA[Programa nacional de prevención de ceguera por retinopatía diabética en Cuba]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>MINSAP</collab>
<source><![CDATA[Anuario estadístico]]></source>
<year>2013</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
